Given the enormous social cost of drug abuse and comparatively small resources for treatment and other medical expenditures, appropriate, timely and effective care could potentially have a large economic impact. Although limitations exist, evidence is growing that drug treatment is often effective, particularly when the treatment strategy is appropriately matched to the user's needs. Yet very few studies to date have examined the cost-effectiveness (CE) of drug treatment. The proposed research will develop methods of conducting CE studies of drug treatment including application of a stochastic simulation model. Most of the data used in the simulation model will be collected at two study sites where we propose to conduct CE analyses of randomized trials of various approaches to aftercare treatment following residential or inpatient treatment. The proposed research has four specific objectives: (1) Develop practical methods for cost analysis that include treatment program, program component, and episode of care costs; (2) Develop multivariate methods for CE analysis that demonstrate the impact of program and client characteristics on treatment costs and effectiveness; (3) Perform a comprehensive CE analysis comparing five approaches to aftercare of varying intensities, including a relapse prevention model; and (4) Develop and test a stochastic simulation model to predict drug use, treatment costs, and other social costs under alternative treatment policies over an addiction career (the periods of active abuse and abstinence over an individual's lifetime of drug abuse). These methods, when utilized by policymakers and program directors, will assist them to determine the most cost effective programs for specific client populations, thus facilitating more appropriate allocation of existing resources. The proposed research will also evaluate whether relapse prevention aftercare is more effective and cost-effective compared to several less costly alternatives. Finally, the proposed research will allow us, through stochastic simulation, to model addiction careers, thus capturing the long-term costs and benefits of substance abuse treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
1R01DA008739-01
Application #
3215127
Study Section
Special Emphasis Panel (SRCD (44))
Project Start
1993-09-30
Project End
1998-08-31
Budget Start
1993-09-30
Budget End
1994-08-31
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Brandeis University
Department
Type
Organized Research Units
DUNS #
616845814
City
Waltham
State
MA
Country
United States
Zip Code
02454
Yeom, Hyong Suk (2011) Gender differences in treatment outcomes among participants in a mixed-gender substance abuse aftercare program. Soc Work Public Health 26:557-76
Yeom, Hyong Suk; Shepard, Donald S (2007) Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences. J Ment Health Policy Econ 10:207-19
Shepard, Donald S; Calabro, Jeanne A B; Love, Craig T et al. (2006) Counselor incentives to improve client retention in an outpatient substance abuse aftercare program. Adm Policy Ment Health 33:629-35
Daley, Marilyn; Shepard, Donald S; Bury-Maynard, Denise (2005) Changes in quality of life for pregnant women in substance user treatment: developing a quality of life index for the addictions. Subst Use Misuse 40:375-94
Shepard, D S (2001) The employer's perspective. Am J Manag Care 7:85-6
McKay, J R; Alterman, A I; Cacciola, J S et al. (1999) Continuing care for cocaine dependence: comprehensive 2-year outcomes. J Consult Clin Psychol 67:420-7
Shepard, D S; Larson, M J; Hoffmann, N G (1999) Cost-effectiveness of substance abuse services. Implications for public policy. Psychiatr Clin North Am 22:385-400, x
Shepard, D S; Stason, W B; Perry Jr, H M et al. (1995) Multivariate cost-effectiveness analysis: an application to optimizing ambulatory care for hypertension. Inquiry 32:320-31